New patent for Optinose Us drug XHANCE

   July 8, 2021    Comments Off on New patent for Optinose Us drug XHANCE    Posted in: Patent Added

Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. There are thirteen patents protecting this drug. XHANCE drug…

The post New patent for Optinose Us drug XHANCE appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog